Accounting for human immune diversity increases clinical relevance of fundamental immunological research; predicts susceptibility to inflammatory disease and cancer survival
Their research gives oncologists a better shot at overcoming the problems of drug resistance, toxicity to patients, and a host of other barriers to consistently achieving successful gene therapy for cancer
An international study was launched when researchers found that another inhibitor for advanced cancers, called OTS167, had a negative outcome in a clinical trial
In the first six weeks, the supplement resulted in 700 grams of gains in lean body mass—the same amount of muscle the men involved in the study would normally have lost in a year